Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces that it has elected to voluntarily adopt semi-annual financial reporting and rely on the exemptions provided under Coordinated Blanket Order 51-933 - Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933"). Introduced by the Canadian Securities Administrators ("CSA"), the pilot program under
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-06-19 12:16 PM EDT | Neural Therapeutics Inc.
Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement
Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on June 16, 2026 indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2.5 million in stockholders' equity for continued listing
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-06-18 5:00 PM EDT | Akanda Corp
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health
Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded it
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-06-18 9:01 AM EDT | Red Light Holland Corp.
Mobile-health Network Solutions Announces Change in Effective Date of Reverse Stock Split
Singapore, Singapore--(Newsfile Corp. - June 18, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a one-for-six reverse stock split (the "Reverse Stock Split") of the Company's Class A Ordinary Shares ("common stock"), which will become effective at 12:01 a.m. Eastern Time on Monday, June 29, 2026. The Company had previously announced that the Reverse Stock Split w
2026-06-18 9:00 AM EDT | Mobile-health Network Solutions
UBERDOC Health Technologies Corp. Announces Proposed Corporate Name Change to Apptly Health Technologies Corp.
Boston, Massachusetts--(Newsfile Corp. - June 18, 2026) - UBERDOC Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) (the "Company") is pleased to announce its intention to change its corporate name to Apptly Health Technologies Corp. ("Apptly"). The rebrand is expected to mark the next chapter in the Company's evolution, from a platform that helps patients book specialists into a leading marketplace for direct-pay healthcare in the United States. The Company's flagship consumer platform will
2026-06-18 8:30 AM EDT | UberDoc
Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million
Markham, Ontario--(Newsfile Corp. - June 18, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, is pleased to announce, that due to strong investor demand, it has increased the size of its previously announced non-brokered private placement financing (the "Offering"). The Company now intends to issue up to 2,000,000 units of the Company (the "Units") at a price of $1.50 per Unit for aggregate gross procee
2026-06-18 7:30 AM EDT | Cheelcare Inc.
BioHarvest Sciences to Present at the 2026 BIO International Convention
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details:
Biotechnology, Pharmaceuticals, Health
2026-06-18 7:30 AM EDT | BioHarvest Sciences Inc.
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-18 7:00 AM EDT | Phio Pharmaceuticals Corp.
Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger
Promino expands its U.S. NCAA NIL platform with Every True Tiger, the third-party marketing arm of the Missouri Tigers, and select student-athletes across leading sports, including football, basketball, wrestling and others. The agreement follows Promino's recently announced VMI NIL partnership and marks another step in the Company's growth across U.S. Division I athletics. Promino continues building athlete-driven awareness behind flagship Promino NSF Ce
Food / Beverages, Sports, Health
2026-06-18 6:00 AM EDT | Promino Nutritional Sciences, Inc.
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand'
Technology, Biotechnology, Health
2026-06-18 6:00 AM EDT | Restart Life Sciences Corp.
Altus Copper Applies for Partial Revocation of Failure-to-File Cease Trade Order, Announces Proposed Financing and Provides Further Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Altus Copper Corp. (the "Company") announces that it has applied to the British Columbia Securities Commission (the "BCSC") and the Ontario Securities Commission (the "OSC") for a partial revocation order (the "Partial Revocation Order") of the failure-to-file cease trade order jointly issued by the BCSC and the OSC on December 5, 2023 (the "FFCTO"). The Company further announces a proposed fina
Food / Beverages, Healthcare and Hospitals, Health
2026-06-17 5:30 PM EDT | Altus Copper Corp.
Hemostemix' $1,000,000 Private Placement and Update
Calgary, Alberta--(Newsfile Corp. - June 17, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that the Company is closing up to $1,000,000 of financing in tranches from the sale of Units at $0.05 each. Each Unit shall consist of one Common Share in the capital of the Company ("Common Share") and one half common share purchase warrant ("1/2 Warrant"), with each whole Warrant (2 x 1/2 Warrants) entitling the holder to acquire one Common Share at a price of $
Biotechnology, Pharmaceuticals, Health
2026-06-17 5:22 PM EDT | Hemostemix Inc.
Tersis and Pingkas Meet with Freeport and Provincial Officials to Explore Potential Project in Bataan, Philippines
Brookville, Florida--(Newsfile Corp. - June 17, 2026) - Representatives from Tersis Technologies (OTCID: TERS) and Pingkas Capital recently met with Authority of the Freeport Area of Bataan (AFAB) administrator Hussein Pangandaman, the Public Private Partnership Investment Center (PPPIC) and their respective teams to discuss potential opportunities for the development of a waste-to-energy project within Bataan, Philippines.
Agriculture, Energy, Alternative Energy, Health
2026-06-17 2:59 PM EDT | Tersis Technologies Inc.
Plaza Capital Invests in Spring Loaded to Accelerate Global Expansion of Innovative Orthopedic Bracing
Halifax, Nova Scotia--(Newsfile Corp. - June 17, 2026) - Spring Loaded Technology Inc., a Canadian medical technology company pioneering novel orthopedic bracing and mobility solutions, today announced a strategic investment from Plaza Capital to support the company's next phase of growth, including international expansion, research and development, and continued advancement of evidence-based mobility solutions. The investment follows Spring Loaded's successful management-led buyout com
2026-06-17 7:00 AM EDT | Spring Loaded Technology
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general and special meeting held June 16, 2026 (the "Meeting"), all of the nominees for election as directors of the Compa
Technology, Computer Software, Healthcare and Hospitals, Health
2026-06-17 7:00 AM EDT | WELL Health Technologies Corp.
Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions
Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce its participation in the BIO International Convention 2026, taking place June 22-25 in San Diego, California. Defence's team will be available throughout the conference to meet with pharmaceutical and biotechnology companies, investors, an
Biotechnology, Pharmaceuticals, Health
2026-06-17 3:15 AM EDT | Defence Therapeutics Inc.
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026. To participate in the call, please dial the following numbers:
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-16 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward in patient care quality. Renowned physician Dr. Brian Browning, DO, Lead Physician at Adia Med, will personally train the company's Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) in ultrasound-guided intravenous (IV) insertions and administrations using the innovative Bu
Healthcare and Hospitals, Health
2026-06-16 10:55 AM EDT | Adia Nutrition Inc.
TelyRx Announces Voting Results from Annual General Meeting of Shareholders
Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the "Meeting"), has been elected. In addition, the other resolution put to vote at the Meeting was passed.
Healthcare and Hospitals, Health
2026-06-15 6:57 PM EDT | TelyRx
Functional Brands Inc. Receives Nasdaq Staff Delisting Determination
Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June 9, 2026, it received a written notification (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Nasdaq has determined to delist the Company's common stock from The Nasdaq Capital Market. As previously disclosed, on D
Household / Consumer / Cosmetics, Health
2026-06-15 8:00 AM EDT | Functional Brands Inc.